NASDAQ:ZSPH ZS Pharma (ZSPH) Stock Price, News & Analysis → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free ZSPH Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get ZS Pharma alerts: Email Address Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story About ZS Pharma Stock (NASDAQ:ZSPH)ZS Pharma, Inc. is a biopharmaceutical company focused on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases. The Company's zirconium silicate technology allows it to create selective ion traps that can reduce toxic levels of specific electrolytes without disturbing the balance of other electrolytes. The Company has completed Phase III development of its product candidate, sodium zirconium cyclosilicate (ZS-9), for the treatment of hyperkalemia, a life-threatening condition in which elevated levels of potassium increase the risk of muscle dysfunction, including cardiac arrhythmias and sudden cardiac death. The Company has completed three clinical studies with ZS-9 for patients with hyperkalemia, including patients with chronic kidney disease (CKD), heart failure (HF), diabetes and those on renin-angiotensin aldosterone system (RAAS) inhibitor therapy.Read More Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story ZSPH Stock News HeadlinesMarch 12, 2024 | seekingalpha.comZscaler: This Is A Dip Well Worth BuyingMarch 4, 2024 | ca.finance.yahoo.comZscaler, Inc. (ZS)April 18, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.February 24, 2024 | benzinga.comZscaler Stock (NASDAQ:ZS), Quotes and News SummaryFebruary 13, 2024 | nasdaq.comZscaler, Inc. Common Stock (ZS)September 2, 2023 | thestreet.comAstraZeneca Gets 'Complete Response Letter' From FDA on Hyperkalaemia TreatmentJune 11, 2023 | wsj.comZscaler Inc.May 21, 2023 | morningstar.comZscaler Inc ZS Stock QuoteApril 18, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.April 6, 2023 | nasdaq.comGuru Fundamental Report for ZSMarch 9, 2023 | finance.yahoo.comKintor Pharma Announces Positive Top-line U.S. Phase I Trial Results of GT20029, the World's First Topical Use PROTAC CompoundJanuary 9, 2023 | thestreet.comZS Pharma (ZSPH) Stock Climbing on Preliminary Acquisition TalksSeptember 24, 2022 | fool.comZscaler (NASDAQ: ZS)May 1, 2022 | thestreet.comZS Pharma, Gilead & Anacor: BioTech Stock Picks on Sell-OffJanuary 5, 2022 | investing.comZs Pharma I (ZSPH)See More Headlines Receive ZSPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ZS Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ZSPH CUSIPN/A CIK1459266 Webwww.zspharma.com Phone+1-650-4584100FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report ZSPH Stock Analysis - Frequently Asked Questions What other stocks do shareholders of ZS Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other ZS Pharma investors own include (RLYP) (RLYP), Jazz Pharmaceuticals (JAZZ), Gilead Sciences (GILD), Pfizer (PFE), Allakos (ALLK), Boeing (BA), Alibaba Group (BABA), Bausch Health Companies (BHC), First Solar (FSLR). This page (NASDAQ:ZSPH) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Next Nvidia?InvestorPlaceHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing1970’s computer coder issues shocking A.I. warningTradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZS Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.